Meeting Banner
Abstract #1067

Erythropoietin (EPO) as Treatment of Mild Traumatic Brain Injury: A Multi Modal MRI Study

Kurt Hermann Bockhorst1, Robert Garcia2, Samson Kujit Gaddam2, Claudia S. Robertson2, Ponnada A. Narayana1

1DII, University of Texas, Houston, TX, United States; 2Neurosurgery, Baylor College of Medicine, Houston, TX, United States

mild traumatic brain injury (mTBI) affects millions of people each year. A treatment is unknown. He we present a potential therapeutic agent, eryrhropoietin, which has been shown to be beneficial in other brain injuries as TBI or global ischemia. We used MRI, especially DTI, to quantify the effects of erythropoietin on mTBI.